Location History:
- Whitton, EN (1976)
- Whitton Twickenham, EN (1977)
Company Filing History:
Years Active: 1976-1977
Title: The Innovative Contributions of Cyril Schneider
Introduction
Cyril Schneider is a notable inventor based in Whitton, GB. He has made significant contributions to the field of therapeutics, holding a total of 2 patents. His work focuses on innovative treatments that address critical health issues.
Latest Patents
Schneider's latest patents include the use of 1-decarboxy-1-hydroxymethyl-PGE.sub.1 in therapeutic applications. This patent describes how the administration of a therapeutically effective dose of 15(S)-1,11.alpha.,15.alpha.-trihydroxy-9-oxo-13-trans-prostene can produce bronchodilation in individuals who require this therapy. Another important patent addresses the treatment of ethanol withdrawal symptoms with levodopa. This invention highlights how levodopa or a composition containing levodopa and a peripheral dopa decarboxylase inhibitor can prevent or suppress withdrawal symptoms in individuals abstaining from ethanol after intoxication.
Career Highlights
Cyril Schneider is associated with Miles Laboratories, Inc., where he continues to develop and refine his innovative ideas. His work has had a meaningful impact on therapeutic practices, particularly in the treatment of respiratory and addiction-related conditions.
Collaborations
Throughout his career, Schneider has collaborated with notable colleagues, including Michael Douglas Hammond and Phillip J Gardiner. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Cyril Schneider's contributions to the field of therapeutics through his patents demonstrate his commitment to innovation and improving health outcomes. His work continues to influence the medical community and offers hope for effective treatments in critical areas.